These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Platelet monoamine oxidase in schizophrenia with beta-phenylethylamine and benzylamine as substrates. Baron M; Perumal AS; Levitt M; Cannova G Biol Psychiatry; 1982 Apr; 17(4):479-83. PubMed ID: 7082713 [No Abstract] [Full Text] [Related]
31. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia. Malas KL; van Kammen DP; deFraites EA; Brown GM; Gold PW Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934 [No Abstract] [Full Text] [Related]
32. Monamine oxidase in schizophrenia and other behavioral disorders. Murphy DL; Belmaker R; Wyatt RJ J Psychiatr Res; 1974; 11():221-47. PubMed ID: 4461792 [No Abstract] [Full Text] [Related]
33. Platelet monoamine oxidase in an aged general population and elderly chronic schizophrenics [[proceedings]. Bridge TP; Jeste DV; Wise CD; Potkin SG; Phelps BH; Wyatt RJ Psychopharmacol Bull; 1981 Jan; 17(1):103-4. PubMed ID: 7232634 [No Abstract] [Full Text] [Related]
34. The schizophrenia syndrome. Examples of biological tools for subclassification. Wyatt RJ; Potkin SG; Kleinman JE; Weinberger DR; Luchins DJ; Jeste DV J Nerv Ment Dis; 1981 Feb; 169(2):100-12. PubMed ID: 7009783 [TBL] [Abstract][Full Text] [Related]
35. Race and platelet MAO activity in schizophrenic patients. Meltzer HY Psychiatry Res; 1988 Dec; 26(3):337. PubMed ID: 3222398 [No Abstract] [Full Text] [Related]
36. Human platelet monoamine oxidase activity and in vivo manipulation of plasma glucose concentration. Jackman HL; Meltzer HY Commun Psychopharmacol; 1980; 4(5):335-8. PubMed ID: 7333090 [No Abstract] [Full Text] [Related]